President Donald Trump’s approval rating has dropped 5

New Post Public Reply Private Reply Replies (1) Message Board
reindeer830 PROFIT$ #35809
274
President Donald Trump’s approval rating has dropped 5 points, equaling his presidency’s low-water mark, since last week’s release of the special counsel report into the 2016 election, according to a new POLITICO/Morning Consult poll.

Despite his sinking poll numbers, however, there is little support for removing Trump through the impeachment process, the poll shows.

Only 39 percent of voters surveyed in the new poll, which was conducted Friday through Sunday, approve of the job Trump is doing as president. That is down from 44 percent last week and ties Trump’s lowest-ever approval rating in POLITICO/Morning Consult polling — a 39 percent rating in mid-August 2017, in the wake of violence in Charlottesville, Va.

Nearly 6 in 10 voters, 57 percent, disapprove of the job Trump is doing.

But while views of Trump have tumbled since the publication of Robert Muller’s redacted report, so has support for impeaching him. Only 34 percent of voters believe Congress should begin impeachment proceedings to remove the president from office, down from 39 percent in January. Nearly half, 48 percent, say Congress should not begin impeachment proceedings.

The split decision in public opinion — a decline in views of Trump’s job performance but fewer voters wanting Congress to pursue impeachment — mirrors the report itself, which clears Trump and his campaign of criminally conspiring with the Russian government to boost his election but which documents numerous, examples of Trump’s efforts to stymie the investigation.

“President Trump’s approval rating has dipped to its lowest point of his term in the immediate aftermath of the redacted Mueller report release,” said Tyler Sinclair, Morning Consult’s vice president. “This week, 57 percent of voters disapprove, and 39 percent approve of the president’s performance — a net approval rating of –18 percentage points, compared with 55 percent who disapproved and 42 percent who approved — a net approval rating of –13 percentage points — one month ago in the aftermath of Attorney General [William] Barr’s summary of the Mueller report to Congress.”

While the report is damaging to Trump in the short term — other post-report polls also show decreases in Trump’s approval rating — it could also paint Democrats into a corner on impeachment. Mueller seemingly kicks the obstruction of justice case on Trump to Congress, and the Democratic-led House is squeezed between a majority of Democratic voters who want impeachment, 59 percent, and slightly more than a third of the electorate that agrees.

For now, most Democrats are treading lightly. In a letter to her Democratic colleagues on Monday, House Speaker Nancy Pelosi acknowledged that her conference’s positions “range from proceeding to investigate the findings of the Mueller report or proceeding directly to impeachment.” And most of the party’s presidential hopefuls have steered clear of impeachment, with Sen. Elizabeth Warren (D-Mass.) being the highest-profile candidate to take the impeachment plunge thus far.

While Democrats in Congress are split on impeachment, most party leaders, including Pelosi, are calling for the House to pull on some of the investigative threads in the Mueller report. Voters are split on whether Congress should continue to investigate whether Trump or his campaign associates and staffers obstructed the investigation: Forty-three percent say Congress should continue to investigate, while 41 percent say it should not.

Nearly three in four Democrats, 73 percent, want Congress to keep investigating, more than the 59 percent who want Congress to begin impeachment proceedings. Most notably, independents are split, 39 percent to 37 percent, on whether Congress should keep investigating — but just 31 percent of independents support beginning impeachment proceedings, compared with 44 percent who oppose impeachment.

As for the report itself, roughly a third of voters, 32 percent, say they have seen, read or heard “a lot about it,” while another third, 34 percent, have seen, read or heard “some” about it. The remaining 34 percent haven’t seen much about it or anything at all.

Among those voters who have seen, read or heard at least something about the release of the Mueller report, only 28 percent say they actually read any of the redacted report. Most of them, 73 percent, say they followed news coverage about it.

A plurality of voters, 46 percent, think the investigation into Russia’s influence on the 2016 presidential election was handled fairly, while 29 percent think it was handled unfairly. There is rare partisan agreement on this question: Forty-eight percent of Democratic voters, 46 percent of Republicans and 43 percent of independents say they think the investigation was handled fairly.

Despite positive grades for the Justice Department, Barr earns lower marks for his handling of the release of information from the Mueller-led investigation. Only three in 10 voters, 30 percent, approve of the way Barr handled the case — less than the 37 percent who disapprove.

Voters were also unsure whether Barr accurately described the contents of Mueller’s report before its release, with 32 percent saying Barr described it very or somewhat accurately, 32 percent saying he didn’t describe it accurately and 35 percent undecided.

Despite Mueller’s report, which “did not establish that the Trump campaign coordinated with the Russian government in its election interference activities,” voters are still split on the question. More than 4 in 10, 41 percent, say they think Trump’s campaign worked with Russia to influence the outcome of the 2016 presidential election. The same percentage, 41 percent, say they don’t think Trump’s campaign worked with Russia. The remaining 18 percent have no opinion.

The results on this question are little changed over the past six weeks. In mid-March, before Barr’s letter to Congress after he received the report, 43 percent thought Trump worked with Russia, while 37 percent did not. Three weeks ago, between Barr’s letter and the release of the report, the percentage of voters who thought Trump’s campaign worked with Russia had ticked down to 40 percent, while 43 percent did not think his campaign worked with Russia.

While voters are divided on whether Trump’s campaign worked with Russia, only 28 percent say they think Mueller found evidence that Trump or his campaign conspired with Russia — though just a 43 percent plurality say Mueller found no evidence of coordination. Three in 10 voters are unsure.

There is greater agreement on whether Trump tried to impede or obstruct the investigation. A plurality, 47 percent, say he did, while just 34 percent say he didn’t. Nearly 2 in 10 voters, 18 percent, have no opinion.

But many voters appear confused about what Mueller found in his report. Two in 10, 20 percent, say Mueller found that Trump obstructed the investigation, while 16 percent say Mueller found that he didn’t. A plurality, 37 percent, say correctly that Mueller did not make a determination on whether Trump obstructed the investigation, but 27 percent are unsure.

The POLITICO/Morning Consult poll surveyed 1,992 voters and has a margin of sampling error of plus or minus 2 percentage points.

Morning Consult is a nonpartisan media and technology company that provides data-driven research and insights on politics, policy and business strategy.

More details on the poll and its methodology can be found in these two documents — Toplines: https://politi.co/2Prrf5R | Crosstabs:https://politi.co/2vgx8cK



Read More: https://investorshangout.com/post/viewremoved...z5m1KNKyiq
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading